Contact Us

DESTINATION NEWS

J INTS BIO and MD Anderson Collaborate on the Development of Brain Tumor Treatment 'JIN-001' - Enhancing Radiation and Chemotherapy Efficacy

Nov 25, 2024

SEOUL,South Korea,Nov. 25,2024-- J INTS BIO announced research findings on its innovative brain tumor treatment,\'JIN-001,\' developed in collaboration with MD Anderson Cancer Center,at the 2024 Socie

Veeva Announces AI in Vault CRM

Nov 25, 2024

CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM SINGAPORE,Nov. 25,2024-- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control,two new GenAI cap

MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation

Nov 25, 2024

SINGAPORE,Nov. 25,2024-- MediSun Energy,a company specializing in advanced osmotic (blue) energy technology,has successfully secured US$8.75 million in Seed financing round and established a strategic

1

Nov 25, 2024

Where river meets sea: Yellow River Delta's call to world

Nov 22, 2024

DONGYING,China,Nov. 21,2024-- A news report fromchinadaily.com.cn: The Yellow River Delta in Dongying,East China\'s Shandong province,has entered its annual peak season for migratory birds. To celebra

InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

Nov 22, 2024

NANJING,China,Nov. 21,2024--InxMed Co.,Ltd,a clinical-stage biotechnology company developing innovative therapies against cancer treatment resistance and metastasis,announced that China National Medic

1 ... 196 197 198 199 200 201 202 ... 356